Australia also already achieved the WHO’s 2020 mortality target. Some might say that this is good news - but at Hepatitis Australia we don’t agree. Virtually every hepatitis C death occurs because the gold-standard treatment and care available in Australia did not reach the person that needed it in time.Read More
Hepatitis Australia posts news stories relating to viral hepatitis that may be relevant to people living with hepatitis B or C or the people working within the hepatitis health sector. News stories come from both international and Australian sources. Your comments are welcome but any inappropriate comments, or promotional comments will be removed.
Patient uptake might be languishing in Australia but England has acted and announced a new deal with companies that will involve the pro-active identification of people living with hepatitis C.Read More
Hepatitis Australia has welcomed outcomes from the March PBAC meeting it says are "cognisant" of the need to address the fall in treatment initiations and an election commitment from the Greens.
The committee recommended a number of revisions to the PBS listing of the direct-acting antivirals for hepatitis C with more "significant changes" on the horizon.Read More
Media Release: 30 April 2019
CEO of Hepatitis Australia, Helen Tyrrell today welcomed the commitment of The Australian Greens to support an immediate increase in funding to help achieve the National Strategy targets for hepatitis B and hepatitis C and avoid lives lost to liver cancer.Read More
The PBAC has recommended a number of revisions to the PBS listing of the direct-acting antivirals for hepatitis C with more "significant changes" on the horizon. This follows "issues raised" at the Hepatitis C stakeholder meeting held in late 2018, which included researchers, clinician and patient groups, were required to sign a confidentiality agreement. Companies with PBS-listed direct-acting antivirals were not invited to the meeting.Read More
Quick Take: The New England Journal of Medicine has posted a new article on 25 April which looks at the success of direct-acting antiviral for curing hepatitis C and what this might mean for organ donation, in particular heart and lung transplants.Read More